Targeting CD30 in malignant tissues: challenges in detection and clinical applications.

about

Brentuximab vedotin in CD30(+) primary cutaneous T-cell lymphomas: a review and analysis of existing data.

P2860

Q38649847-340986F9-3D0A-4012-AEFA-AF40E7183C5C

P2860

Targeting CD30 in malignant tissues: challenges in detection and clinical applications.

Item

http://www.wikidata.org/entity/Q38108134

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targeting CD30 in malignant tissues: challenges in detection and clinical applications.

@en

type

Item

label

Targeting CD30 in malignant tissues: challenges in detection and clinical applications.

@en

prefLabel

Targeting CD30 in malignant tissues: challenges in detection and clinical applications.

@en

P1476

Targeting CD30 in malignant tissues: challenges in detection and clinical applications.

@en

P2093

Gretchen S Jimenez

http://www.w3.org/2001/XMLSchema#string

Mariusz A Wasik

http://www.w3.org/2001/XMLSchema#string

P2860

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Roles for CD30 in the biology and treatment of CD30 lymphoproliferative diseases

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

Technical pitfalls potentially affecting diagnoses in immunohistochemistry.

Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies.

Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues.

CD30+ neoplasms of the skin.

Polychromatic flow cytometry in the clinical laboratory.

CD30+ lymphoproliferative disorders

Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis.

P304

252-258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000347192

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dennis D Weisenburger

P577

2013-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23689361

http://www.w3.org/2001/XMLSchema#string

Targeting CD30 in malignant tissues: challenges in detection and clinical applications.

about

P2860

P2860

Targeting CD30 in malignant tissues: challenges in detection and clinical applications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698